
Epila Formulations & Services Private Limited
About Epila Formulations & Services Private Limited
Data last updated:
Epila Formulations & Services Private Limited is a private limited company based in Patna, Bihar, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 05 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U43299BR2018PTC037340. Its GSTIN is 10AAECE9541R1ZA (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors Durg Nandan Sahai (Managing Director) and Bina Rani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O:Durga Nand Sahay Dev Niwas B.N Verma Road Mithapur Gardanibagh, Patna, Bihar, India – 800001.
As per the financials filed for FY 2025, the company reported a revenue of ₹41.96 Lakh, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹2,230 (net margin 0.1%) and EBITDA of ₹15,060 (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 73% over three years and 41% over five years.
Company details
CIN history
Epila Formulations & Services has one previous CIN (Corporate Identification Number): U74999BR2018PTC037340. The current CIN is U43299BR2018PTC037340, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U43299BR2018PTC037340 | Current |
| U74999BR2018PTC037340 | Previous |
Contact details
Epila Formulations & Services Private Limited's registered office is in Patna, Bihar.
- Registered AddressC/O:Durga Nand Sahay Dev Niwas B.N Verma Road Mithapur Gardanibagh, Patna, Bihar, India – 800001
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Epila Formulations & Services is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Epila Formulations & Services Private Limited, buy the company report.
Financials of Epila Formulations & Services Private Limited
FY 2025 filings availableEpila Formulations & Services Private Limited reported revenue of ₹41.96 Lakh (up 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 41% over five years, including 31% growth in the latest year. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15,060 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,230 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Epila Formulations & Services Private Limited, buy the company report.
Board of directors of Epila Formulations & Services Private Limited
Epila Formulations & Services has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bina Rani Also directs: Alderma Private Limited | Director | 05 Mar 2018 | 8 Years 8 Months | Current |
| Durg Nandan Sahai Also directs: Alderma Private Limited | Managing Director | 05 Mar 2018 | 8 Years 8 Months | Current |
Peer comparison
Epila Formulations & Services Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Newtech Pharmaceuticals Private Limited | ₹42.14 Lakh (FY 2024) | -49.0% | Saharanpur, Uttar Pradesh, India | |||
| Newel Lifesciences Private Limited | ₹42 Lakh (FY 2024) | -37.0% | Ahmedabad, Gujarat, India | |||
| Epila Formulations & Services Private Limitedthis company | ₹41.96 Lakh (FY 2025) | ₹2,230 | 0.1% | 31.0% | Patna, Bihar, India | |
| Chakrachem Lifesciences Private Limited | ₹41.75 Lakh (FY 2025) | 1.0% | Hyderabad, Telangana, India | |||
| Martinsynge Pharma Sciences Private Limited | ₹41.65 Lakh (FY 2021) | -55.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Epila Formulations & Services Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Epila Formulations & Services Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Epila Formulations & Services Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Epila Formulations & Services has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECE9541R1ZA | Bihar | Active | 28 Mar 2018 |
To see the full GST registrations and return filing status of Epila Formulations & Services Private Limited, buy the company report.
Recent activity
Epila Formulations & Services Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Siya Sharan Thakur ceased to be Director on 30 Jul 2019.
Frequently asked questions
Epila Formulations & Services is an active private limited company based in Patna, Bihar, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 05 March 2018 (8+ years old) and is registered under CIN U43299BR2018PTC037340.
Epila Formulations & Services has 2 current directors:
- Durg Nandan Sahai - Managing Director
- Bina Rani - Director
The latest financial statements of Epila Formulations & Services on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Epila Formulations & Services is 10AAECE9541R1ZA, registered in Bihar.
The CIN (Corporate Identification Number) of Epila Formulations & Services is U43299BR2018PTC037340. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Epila Formulations & Services was incorporated on 05 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Epila Formulations & Services by revenue are Newtech Pharmaceuticals Private Limited, Newel Lifesciences Private Limited, Chakrachem Lifesciences Private Limited, Martinsynge Pharma Sciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Siya Sharan Thakur ceased to be Director on 30 Jul 2019. Bina Rani was appointed as Director on 05 Mar 2018. Durg Nandan Sahai was appointed as Managing Director on 05 Mar 2018.
The registered office of Epila Formulations & Services is at CO:Durga Nand Sahay Dev Niwas B.N Verma Road Mithapur Gardanibagh, Patna, Bihar, India – 800001.
Epila Formulations & Services operates in the business services industry, in the miscellaneous business activities segment.
Epila Formulations & Services can be reached at its registered office: CO:Durga Nand Sahay Dev Niwas B.N Verma Road Mithapur Gardanibagh, Patna, Bihar, India – 800001.

